The University of Chicago Header Logo

Connection

David Onsager to Muromonab-CD3

Back to Details
This is a "connection" page, showing publications David Onsager has written about Muromonab-CD3.
David Onsager
Connection Strength
0.041
Muromonab-CD3
  1. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients. J Heart Lung Transplant. 1999 May; 18(5):448-55.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.